Page last updated: 2024-11-08

serine and Glycogen Storage Disease Type I

serine has been researched along with Glycogen Storage Disease Type I in 1 studies

Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.

Glycogen Storage Disease Type I: An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hornemann, T1
Alecu, I1
Hagenbuch, N1
Zhakupova, A1
Cremonesi, A1
Gautschi, M1
Jung, HH1
Meienberg, F1
Bilz, S1
Christ, E1
Baumgartner, MR1
Hochuli, M1

Other Studies

1 other study available for serine and Glycogen Storage Disease Type I

ArticleYear
Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I - A link to metabolic control.
    Molecular genetics and metabolism, 2018, Volume: 125, Issue:1-2

    Topics: Adolescent; Adult; Alanine; Female; Glucose; Glycogen Storage Disease Type I; Humans; Lipid Metaboli

2018